Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on September 7, 2006

Stroke. 2006
Published online before print September 7, 2006, doi: 10.1161/01.STR.0000242481.38262.7b
A more recent version of this article appeared on October 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/10/2562    most recent
01.STR.0000242481.38262.7bv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gupta, R.
Right arrow Articles by Jovin, T. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gupta, R.
Right arrow Articles by Jovin, T. G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*TAXOL
Related Collections
Right arrow Angioplasty and Stenting
Right arrow Restenosis
Right arrow Angiography

Submitted on June 1, 2006
Revised on June 28, 2006
Accepted on July 12, 2006

Safety, Feasibility, and Short-Term Follow-Up of Drug-Eluting Stent Placement in the Intracranial and Extracranial Circulation

Rishi Gupta MD; Firas Al-Ali MD; Ajith J. Thomas MD; Michael B. Horowitz MD; Thomas Barrow RN; Nirav A. Vora MD; Ken Uchino MD; Maxim D. Hammer MD; Lawerence R. Wechsler MD; and Tudor G. Jovin MD*

From the Department of Neurology (R.G., N.A.V., K.U., M.D.H., L.R.W., T.G.J.), University of Pittsburgh Medical Center, Pittsburgh, Pa; the Department of Neurology (R.G.), Michigan State University, East Lansing; Neurosurgery of Kalamazoo, LLC (F.A.-A., T.B.), Kalamazoo, Mich; and the Department of Neurosurgery (A.J.T., M.B.H., T.G.J.), University of Pittsburgh Medical Center, Pittsburgh, Pa.

* To whom correspondence should be addressed. E-mail: jovintg{at}upmc.edu.

Background and Purpose--The use of bare metal stents to treat symptomatic intracranial stenosis may be associated with significant restenosis rates. The advent of drug-eluting stents (DESs) in the coronary circulation has resulted in a reduction of restenosis rates. We report our technical success rate and short-term restenosis rates after stenting with DESs in the intracranial and extracranial circulation.

Methods--This study was a retrospective review of the period between April 1, 2004, and April 15, 2006, of 59 patients with 62 symptomatic intracranial or extracranial atherosclerotic lesions at 2 medical centers (University of Pittsburgh and Borgess Medical Center).

Results--The mean age of our cohort was 61±12 years. The location of the 62 lesions was as follows: extracranial vertebral artery 31 (50%), intracranial vertebral artery or basilar artery 18 (29%), extracranial internal carotid artery (ICA) near the petrous bone 5 (8%), and intracranial ICA 8 (13%). There were 2 (3%) periprocedural complications: 1 non--flow-limiting dissection and 1 disabling stroke. Fifty vessels were available for follow-up angiography or computed tomography angiography at a median time of 4.0±2 months. A total of 2 of 36 extracranial stents (7%) and 1 of 26 intracranial stents (5%) were found to have restenosis ≥50% at follow-up.

Conclusions--This report demonstrates that DES delivery in the intracranial and extracranial circulation is technically feasible. A small percentage of patients developed short-term in-stent restenosis. Longer-term follow-up is required in the setting of a prospective study to determine the late restenosis rates for DESs in comparison with bare metal stents.


Key words: angioplasty • intracranial stenosis • stenting • stents




This article has been cited by other articles:


Home page
StrokeHome page
M. Mazighi, J. S. Yadav, and A. Abou-Chebl
Durability of Endovascular Therapy for Symptomatic Intracranial Atherosclerosis
Stroke, June 1, 2008; 39(6): 1766 - 1769.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
O. O. Zaidat, R. Klucznik, M. J. Alexander, J. Chaloupka, H. Lutsep, S. Barnwell, M. Mawad, B. Lane, M. J. Lynn, M. Chimowitz, et al.
The NIH registry on use of the Wingspan stent for symptomatic70-99% intracranial arterial stenosis
Neurology, April 22, 2008; 70(17): 1518 - 1524.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
A.S. Turk, E.I. Levy, F.C. Albuquerque, G.L. Pride Jr, H. Woo, B.G. Welch, D.B. Niemann, P.D. Purdy, B. Aagaard-Kienitz, P.A. Rasmussen, et al.
Influence of Patient Age and Stenosis Location on Wingspan In-Stent Restenosis
AJNR Am. J. Neuroradiol., January 1, 2008; 29(1): 23 - 27.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. Fiorella and H. H. Woo
Emerging Endovascular Therapies for Symptomatic Intracranial Atherosclerotic Disease
Stroke, August 1, 2007; 38(8): 2391 - 2396.
[Full Text] [PDF]


Home page
J Ultrasound MedHome page
E. Vicenzini, F. Puccinelli, M. C. Ricciardi, G. Guidetti, R. Delfini, and G. L. Lenzi
Contrast-Enhanced Transcranial Color-Coded Duplex Sonography Versus Computed Tomography and Magnetic Resonance Angiography in the Follow-up of Basilar Stenting
J. Ultrasound Med., April 1, 2007; 26(4): 543 - 546.
[Full Text] [PDF]


Home page
StrokeHome page
D. M. Pelz, E. I. Levy, and L. N. Hopkins
Advances in Interventional Neuroradiology 2006
Stroke, February 1, 2007; 38(2): 232 - 234.
[Full Text] [PDF]